LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ: ITEK), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases, today announced that David P. Southwell, President and Chief Executive Officer of Inotek, will present a company overview at the following conferences:
• Cantor Fitzgerald’s 2nd Annual Healthcare Conference on, July 12th, 2016 at 1:30 p.m. EDT in New York City.
